Discontinued — last reported Q3 '20
Debt Instrument, Fair Value Disclosure
West Pharmaceutical Services Debt Instrument, Fair Value Disclosure decreased by 0.1% to $202.20M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 0.5%, from $201.20M to $202.20M. Over 2 years (FY 2023 to FY 2025), Debt Instrument, Fair Value Disclosure shows relatively stable performance with a -0.5% CAGR.
Analysis
How to read this metric
If the fair value is significantly lower than the carrying amount, it may indicate an opportunity to repurchase debt at a discount or reflect rising market interest rates.
Detailed definition
This represents the estimated fair market value of the company's total debt obligations, which may differ from the carry...
Peer comparison
Publicly traded companies with significant bond issuances are required to disclose this to show the market's current valuation of their credit risk.
other_debt_instrument_fair_valueHistorical Data
| Q4 '23 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|
| Value | $204.40M | $203.00M | $201.60M | $200.50M | $201.20M | $201.90M | $202.10M | $202.40M | $202.20M |
| QoQ Change | — | -0.7% | -0.7% | -0.5% | +0.3% | +0.3% | +0.1% | +0.1% | -0.1% |
| YoY Change | — | — | — | -1.9% | — | -0.5% | +0.2% | +0.9% | +0.5% |
Debt Instrument, Fair Value Disclosure at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's debt instrument, fair value disclosure?
- West Pharmaceutical Services (WST) reported debt instrument, fair value disclosure of $202.20M in Q1 2026.
- How has West Pharmaceutical Services's debt instrument, fair value disclosure changed year-over-year?
- West Pharmaceutical Services's debt instrument, fair value disclosure increased by 0.5% year-over-year, from $201.20M to $202.20M.
- What is the long-term trend for West Pharmaceutical Services's debt instrument, fair value disclosure?
- Over 2 years (2023 to 2025), West Pharmaceutical Services's debt instrument, fair value disclosure has grown at a -0.5% compound annual growth rate (CAGR), from $204.40M to $202.40M.
- What does debt instrument, fair value disclosure mean?
- The current market price to buy back or pay off the company's debt.